64 related articles for article (PubMed ID: 10755493)
1. How autism and Alzheimer's disease are TrAPPed.
Lahiri DK; Maloney B; Wang R; Sokol DK; Rogers JT; Westmark CJ
Mol Psychiatry; 2021 Jan; 26(1):26-29. PubMed ID: 33184495
[No Abstract] [Full Text] [Related]
2. Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease.
Yankner BA; Lu T
J Biol Chem; 2009 Feb; 284(8):4755-9. PubMed ID: 18957434
[No Abstract] [Full Text] [Related]
3. Amyloid diseases: abnormal protein aggregation in neurodegeneration.
Koo EH; Lansbury PT; Kelly JW
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):9989-90. PubMed ID: 10468546
[No Abstract] [Full Text] [Related]
4. The implications of amyloid-β pathology: only time will tell.
Coomans EM; Ossenkoppele R
Brain; 2024 Jun; 147(6):1934-1936. PubMed ID: 38752398
[No Abstract] [Full Text] [Related]
5. Novel therapeutics for Alzheimer's disease.
Tanzi RE
Neurotherapeutics; 2008 Jul; 5(3):377-80. PubMed ID: 18625448
[No Abstract] [Full Text] [Related]
6. Get moving to clear β-amyloid.
Ferrarelli LK
Sci Signal; 2023 Dec; 16(814):eadn2344. PubMed ID: 38051777
[TBL] [Abstract][Full Text] [Related]
7. Is amyloid-β a friend or foe?
Durrant CS
Nat Rev Mol Cell Biol; 2024 Jul; 25(7):516. PubMed ID: 38698078
[No Abstract] [Full Text] [Related]
8. The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain.
Gavín R; Lidón L; Ferrer I; Del Río JA
Cells; 2020 Mar; 9(3):. PubMed ID: 32131451
[TBL] [Abstract][Full Text] [Related]
9.
Youn YC; Jang JW; Han SH; Kim H; Seok JW; Byun JS; Park KY; An SSA; Chun IK; Kim S
Clin Interv Aging; 2017; 12():1041-1048. PubMed ID: 28721032
[TBL] [Abstract][Full Text] [Related]
10. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
11. Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.
Ghoshal N; Cali I; Perrin RJ; Josephson SA; Sun N; Gambetti P; Morris JC
Arch Neurol; 2009 Oct; 66(10):1240-6. PubMed ID: 19822779
[TBL] [Abstract][Full Text] [Related]
12. Cross currents in protein misfolding disorders: interactions and therapy.
Morales R; Green KM; Soto C
CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):363-71. PubMed ID: 19702573
[TBL] [Abstract][Full Text] [Related]
13. Twenty-first century brain banking: practical prerequisites and lessons from the past: the experience of New York Brain Bank, Taub Institute, Columbia University.
Vonsattel JP; Amaya Mdel P; Cortes EP; Mancevska K; Keller CE
Cell Tissue Bank; 2008 Sep; 9(3):247-58. PubMed ID: 18581261
[TBL] [Abstract][Full Text] [Related]
14. Neuropathological characterisation of French bovine spongiform encephalopathy cases.
Debeer S; Baron T; Bencsik A
Histochem Cell Biol; 2003 Dec; 120(6):513-21. PubMed ID: 14624299
[TBL] [Abstract][Full Text] [Related]
15. Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology.
Leuba G; Saini K; Savioz A; Charnay Y
JAMA; 2000 Apr; 283(13):1689-91. PubMed ID: 10755493
[No Abstract] [Full Text] [Related]
16. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
Price DL; Borchelt DR; Sisodia SS
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988
[TBL] [Abstract][Full Text] [Related]
17. Prions, prionoids and pathogenic proteins in Alzheimer disease.
Ashe KH; Aguzzi A
Prion; 2013; 7(1):55-9. PubMed ID: 23208281
[TBL] [Abstract][Full Text] [Related]
18. Medicine. Prion-like behavior of amyloid-beta.
Kim J; Holtzman DM
Science; 2010 Nov; 330(6006):918-9. PubMed ID: 21071652
[No Abstract] [Full Text] [Related]
19. Prion-like mechanisms in Alzheimer disease.
Walker LC
Handb Clin Neurol; 2018; 153():303-319. PubMed ID: 29887142
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
